The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours

Documenti analoghi

• The geographical distribution of neuroendocrine neoplasms in England (2012–2018)
  di: Chinonso A. Nwoguh, et al.
  Pubblicazione: (2025)
• Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours
  di: Jelka Kuiper, et al.
  Pubblicazione: (2024)
• Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors
  di: Giulia Santo, et al.
  Pubblicazione: (2025)
• Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
  di: Stefano Partelli, et al.
  Pubblicazione: (2026)
• Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms
  di: Simona Grozinsky‐Glasberg, et al.
  Pubblicazione: (2025)